Announcements Trials
Browse Landscape

Phase

Phase NA 47Phase 2 7Phase 4 2Phase 2/3 2Phase 3 1Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Breast Neoplasms 207Neoplasms 130Polycystic Ovary Syndrome 107Carcinoma, Hepatocellular 82Colorectal Neoplasms 76Prostatic Neoplasms 70Stomach Neoplasms 55Lung Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Carcinoma, Non-Small-Cell Lung 43Pancreatic Neoplasms 41Pain, Postoperative 41Head and Neck Neoplasms 38Pain 37Liver Neoplasms 36Leukemia, Myeloid, Acute 32Leiomyoma 32Keratosis, Actinic 31Colonic Neoplasms 31Recurrence 30Neoplasm Metastasis 29Multiple Myeloma 28Infertility 28Brain Neoplasms 28Uterine Cervical Neoplasms 26Urinary Bladder Neoplasms 24Ovarian Neoplasms 24Lymphoma 24Esophageal Neoplasms 23Obesity 22

Interventions

Immunonutrition Diet 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Frailty × Clear all
NCT03642093 2018-09-11

HOPE

Ochsner Health System

Phase 4 Unknown
60 enrolled
Gastrointestinal

Frailty, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT03465202 2018-03-14

Association of Capecitabine Pharmacokinetics and Toxicity With Aging

Newcastle-upon-Tyne Hospitals NHS Trust

Phase 4 Unknown
100 enrolled
BreastGastrointestinal

Frailty, Breast Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡